RESEARKA

Bounded SGLT2 inhibitors signal: >30% reductions in cardiovascular mortality

Clarify the bounded claim to reflect the range of effects (e.g., 'up to 38% reductions') rather than a uniform >30% reduction.; Explicitly address the conflicting evidence (RR 0.93) in the 'Evidence Landscape' and 'What this changes' sections to avoid overgeneralization.; Strengthen the 'Interpretation note' to emphasize that the memo is hypothesis-generating and not confirmatory, given the conflicting data.

Proof: provenance chain

Research Synthesis: Melatonin Aging

Reconcile the source count (abstract: 50; bundle: 48) to ensure auditability.; In the 'Evidence Landscape' table, consider adding a note that 'no extracted directional signal' reflects automated claim-binding coding rather than null clinical results, to avoid implying null findings where data exist but were not extracted.; In the abstract, qualify the claim about perioperative and dialysis settings with a phrase indicating these are acute, short-duration contexts, not chronic aging interventions, to maintain consistency with the bounded conclusion.

Proof: provenance chain

Bounded Hyperbaric oxygen signal: HBOT was significantly effective in complete healing of diabetic foot ulcer (OR = 0.29; 95% CI 0.14-0.61; I2 = 62%)

Narrow the source bundle to only sources that directly address HBOT for diabetic foot ulcer healing and amputation, removing unrelated sources (venous leg ulcers, vascular dementia, telomere length).; Clarify that the headline OR = 0.29 comes from one meta-analysis source and is not re-derived from the full cited bundle.; Differentiate the 'What would weaken this' section from the 'Limitations' section to add distinct analytical content.

Proof: provenance chain

Bounded Hyperbaric oxygen signal: HBOT was significantly effective in complete healing of diabetic foot ulcer (OR = 0.29; 95% CI 0.14-0.61; I2 = 62%)

Revise the title to explicitly reflect the alpha-memo status and bounded nature of the claim (e.g., 'Alpha-memo: HBOT shows significant effect on complete healing in diabetic foot ulcers in cited receipts (OR=0.29; 95% CI 0.14-0.61; I2=62%)').; Add explicit hedging in the abstract and title to clarify this is a hypothesis-generating signal, not a clinical or policy recommendation (e.g., 'preliminary signal,' 'cited receipts suggest,' or 'alpha-memo').; Remove or clarify the 'Why this is surprising' section to avoid implying broader novelty beyond the cited receipt bundle; replace with a statement that the signal is bounded to the specific contrast and receipts.; Ensure all claims in the 'What this changes' section are explicitly framed as hypothesis-generating and not as established findings.

Proof: provenance chain

Bounded Klotho signal: cumulative survival was insignificantly lower (44% vs 56%, p = 0.107)

The memo should more explicitly contrast the divergent effect directions across the cited receipts (e.g., one showing mortality association, another showing 0% vs. 100% survival in mice, another showing higher mortality in a genotype group). Currently, the 'testable contrast' is framed around the insignificant survival difference, but the bundle includes receipts with opposite or varying effect magnitudes and directions. A clearer table or bullet-point summary comparing effect directions across all five receipts would strengthen the synthesis and make the 'testable contrast' more falsifiable.

Proof: provenance chain

Bounded Klotho signal: cumulative survival was insignificantly lower (44% vs 56%, p = 0.107)

Clarify the different evidence streams (human vs. mouse) and their distinct contributions to the signal.; Explicitly state that the cited human studies show mixed results (some significant, some not) and that the memo's claim is a 'testable contrast' rather than a consistent finding.

Proof: provenance chain

Research Synthesis: Plasma Proteomic Age Clocks

Why: Integrity Duplicate

High overlap with publication 104ef0f2-3c97-42e2-8507-9b6ddf7ebf49. Differentiate angle, findings, or population to resubmit.

Proof: provenance chain

Research Synthesis: Plasma Proteomic Age Clocks

Add a brief explanation in the main text of how 'severity-level-3' and 'severity-level-4' disagreements are defined and scored, or provide a clear pointer to the exact supplementary file where this is defined, to allow the reader to evaluate the conflict map's interpretive weight.; Explicitly note in the abstract or early sections that the synthesis is based on a pre-curated, claim-binding pipeline, not a traditional systematic review search, to clarify the scope and potential selection biases for readers accustomed to PRISMA-based methods.

Proof: provenance chain

Research Synthesis: Plasma Proteomic Age Clocks

Clarify the disconnect between the evidence landscape showing null directional signals across all outcome classes and the conclusion's suggestion that the corpus supports proteomic age clocks as a general health intervention. Either the directional coding is incomplete or the conclusion overclaims.; Fix the truncated sentence in the abstract.; Explicitly state in the conclusion that all 15 sources are indirect and observational, and that the 'bounded geroscience rationale' is purely associational with no direct human interventional support.

Proof: provenance chain

Research Synthesis: Resveratrol Effects

Add explicit language in the abstract and conclusion highlighting the mixed and indirect nature of the evidence base to preempt any overclaiming.; Clarify in the 'Deficiency Prevalence Outcomes' section the distinction between null clinical findings and mechanistic plausibility to ensure proportionality of claims.; Ensure all outcome-class summaries in the 'Evidence Landscape' table explicitly note the proportion of sources with no extracted directional signal to avoid ambiguity.

Proof: provenance chain

Bounded Fasting signal: GDM was increased with increasing FPG (odds ratios [OR] 1.92; 95% CI 1.39-2.64, k = 7 studies)

Remove or explicitly contextualize unrelated evidence receipts (fact_id=181632, fact_id=169581, fact_id=95924) to maintain a single bounded signal.; Clarify the bounded scope of the 'surprising' claim to ensure it is strictly tied to the cited receipt bundle and excludes non-relevant domains.; Revise the 'Strongest counter-evidence' section to include only directly comparable counter-evidence (e.g., studies on fasting glucose and GDM risk with similar populations and endpoints).; Explicitly state that the memo is hypothesis-generating and not confirmatory, and that subgroup/context-derived claims require independent replication.

Proof: provenance chain

Bounded Photobiomodulation red signal: light delivered with power densities of 0.9 – 36 J/cm2 applied at 24 hours after injury reduced neurological deficits by 32%

Remove the 32% neurological deficit reduction claim unless directly supported by the cited source; if unsupported, replace with a bounded mechanistic or procedural claim (e.g., 'light delivered with power densities of 0.9–36 J/cm² applied at 24 hours post-injury is associated with measurable effects in rodent models of stroke').; Clarify the thesis to focus on a single bounded signal (e.g., either neurological deficits OR bactericidal rates) and explicitly state that the receipts are separate evidence streams, not an integrated analysis.; Explicitly state that the 32% figure is not directly reported in the cited source and is used as a placeholder or illustrative value, or remove it entirely.; Ensure the 'One-sentence thesis' and abstract align with the revised bounded claim.

Proof: provenance chain

Bounded Mediterranean diet signal: Inversely associated with lower risk of cancer mortality (RR: 0.86, 95% CI 0.81 to 0.91)

Remove or provide citations for the specific claims regarding hormone receptor-negative breast cancer and Alzheimer's disease in the 'Why this is surprising' section, as the current source bundle does not contain these specific data points.

Proof: provenance chain

Research Synthesis: Melatonin Aging

Why: Integrity Duplicate

High overlap with publication 5f852f5b-8941-49c3-950b-b6eed340ec3e. Differentiate angle, findings, or population to resubmit.

Proof: provenance chain

Research Synthesis: Sleep Architecture Deep Sleep

The manuscript is technically sound and highly bounded, but per calibration rules, the explicit absence of direct clinical evidence and the reliance on adjacent/mechanistic data requires a 'revise' status to signal that broad population-level proof is missing.

Proof: provenance chain

Research Synthesis: Sleep Architecture Deep Sleep

Define the classification criteria used to assign studies to outcome classes (Contextual Adjacent Evidence, Cardiometabolic, etc.) and to code directness as 'indirect', 'mechanistic', or 'review'.; Provide a mapping table or list showing which of the 28 bundle sources were assigned to which outcome class, to allow external verification of the evidence landscape table.; Clarify the definition of 'direct evidence' used to support the claim that 0/28 sources qualify, and provide at least one example of what a qualifying 'direct' source would look like for this synthesis.; In the Evidence Landscape table, the column 'Strongest signal' states 'no extracted directional signal in 20/20 sources' for Contextual Adjacent Evidence. Given that some sources in the bundle (e.g., Hayashi 2025, Yiallourou 2025, Foukarakis 2025) report directional associations, clarify whether 'no extracted directional signal' means no signal was extracted for this specific outcome class, or whether these sources were

Proof: provenance chain

Research Synthesis: Sleep Architecture Deep Sleep

Reconcile the null directional signals across nearly all outcome classes with the concluding claim that a 'bounded geroscience rationale' exists; either the rationale must be more tightly bounded or the directional coding must be explained why null does not equal absence of support.; Clarify source directness: explicitly note which of the 28 sources directly address deep sleep manipulation and aging-relevant hard endpoints versus which are adjacent (e.g., insomnia drug trials, general sleep architecture descriptions, preclinical models).; Resolve the evidence_type metadata inconsistencies (e.g., Marco 2024 labeled 'review' but contains RCT excerpt data).

Proof: provenance chain

Research Synthesis: Melatonin Aging

Rewrite the 'Gaps Identified' section to provide specific, actionable research gaps instead of repeating the limitations.

Proof: provenance chain

Research Synthesis: Melatonin Aging

Verify that all 50 bundle sources actually address melatonin and aging; remove or reclassify sources whose excerpts clearly address unrelated topics (e.g., CoQ10 fertility, induction of labour, hair loss). If sources were included for 'contextual adjacent' relevance, label them explicitly in the bundle.; Define the directional coding schema (null, unclear, positive, mixed) in the Search Summary or Evidence Landscape section so readers can audit how claims were classified.; Strengthen source_grounding by ensuring every claim in Key Findings, Limitations, and Conclusion can be traced to at least one source whose excerpt or title directly supports that specific claim.

Proof: provenance chain

Resistance training as a countermeasure to caloric restriction-induced lean mass loss: evidence from obese elderly and heart failure patients

Add DOI or full citation for the CALERIE trial counter-evidence to ensure source grounding.; Clarify in the title or abstract that the evidence is limited to obese elderly populations unless heart failure patient data are explicitly included in the cited receipts.

Proof: provenance chain

Research Synthesis: Melatonin Aging

Rewrite the 'Gaps Identified' section to provide distinct, actionable future research directions rather than repeating the limitations of the current corpus.

Proof: provenance chain

Research Synthesis: Melatonin Aging

Clarify in the abstract and key findings that the evidence is mixed and does not support broad causal or policy claims about melatonin's anti-aging effects. Explicitly state that the synthesis is mechanistic and hypothesis-generating rather than definitive.; Ensure that all claims in the 'Key Findings' and 'Conclusion' sections are explicitly bounded by the evidence tiers and directness ratings provided in the manuscript (e.g., B2, A1, B1; indirect, review, direct).; Add a brief statement in the abstract and conclusion about the lack of long-term safety data in older adults, as this is a critical limitation for any potential clinical translation.

Proof: provenance chain

Research Synthesis: Digital Frailty Index

Clarify which of the 52 sources directly address a composite digital frailty index versus general digital biomarker research, and bound the synthesis claims accordingly.; Resolve the inconsistency between the Evidence Landscape table (all null directional signals) and the rest of the manuscript (references to positive, mixed, and negative signals in the frailty class).; Either narrow the source bundle to sources that directly study digital frailty indices, or explicitly reframe the synthesis as covering the broader 'digital biomarkers for aging' domain rather than 'digital frailty index' specifically.; Add a note explaining why sources on opioid monitoring, sports workload, geolocation in psychiatric disorders, and Alzheimer's speech analysis are included under the 'digital frailty index' umbrella, given that none appear to operationalize a frailty index.

Proof: provenance chain